Mayne Pharma Group Limited HG6.F Stock
Mayne Pharma Group Limited Price Chart
Mayne Pharma Group Limited HG6.F Financial and Trading Overview
| Mayne Pharma Group Limited stock price | 3.02 EUR |
| Previous Close | 2.4 EUR |
| Open | 2.42 EUR |
| Bid | 2.42 EUR x 1000000 |
| Ask | 2.46 EUR x 1000000 |
| Day's Range | 2.42 - 2.42 EUR |
| 52 Week Range | 1.74 - 5.24 EUR |
| Volume | 1K EUR |
| Avg. Volume | 17 EUR |
| Market Cap | 208.61M EUR |
| Beta (5Y Monthly) | 0.992337 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.95 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | January 18, 2023 |
| 1y Target Est | N/A |
HG6.F Valuation Measures
| Enterprise Value | 128.06M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.5554574 |
| Price/Book (mrq) | 0.2675216 |
| Enterprise Value/Revenue | 0.341 |
| Enterprise Value/EBITDA | -1.513 |
Trading Information
Mayne Pharma Group Limited Stock Price History
| Beta (5Y Monthly) | 0.992337 |
| 52-Week Change | -1.56% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.24 EUR |
| 52 Week Low | 1.74 EUR |
| 50-Day Moving Average | 2.35 EUR |
| 200-Day Moving Average | 2.55 EUR |
HG6.F Share Statistics
| Avg. Volume (3 month) | 17 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 85.07M |
| Float | 60.52M |
| Short Ratio | N/A |
| % Held by Insiders | 24.82% |
| % Held by Institutions | 16.47% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 20.51% |
| Operating Margin (ttm) | -39.92% |
| Gross Margin | 30.43% |
| EBITDA Margin | -22.53% |
Management Effectiveness
| Return on Assets (ttm) | -6.32% |
| Return on Equity (ttm) | -43.54% |
Income Statement
| Revenue (ttm) | 375.56M EUR |
| Revenue Per Share (ttm) | 4.53 EUR |
| Quarterly Revenue Growth (yoy) | -32.70% |
| Gross Profit (ttm) | 171.03M EUR |
| EBITDA | -84641000 EUR |
| Net Income Avi to Common (ttm) | -326335008 EUR |
| Diluted EPS (ttm) | -2.71 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 175.54M EUR |
| Total Cash Per Share (mrq) | 1.99 EUR |
| Total Debt (mrq) | 81.23M EUR |
| Total Debt/Equity (mrq) | 10.18 EUR |
| Current Ratio (mrq) | 1.454 |
| Book Value Per Share (mrq) | 9.046 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -64414000 EUR |
| Levered Free Cash Flow (ttm) | -150407872 EUR |
Profile of Mayne Pharma Group Limited
| Country | Germany |
| State | SA |
| City | Salisbury South |
| Address | 1538 Main North Road |
| ZIP | 5106 |
| Phone | 61 8 8209 2666 |
| Website | https://www.maynepharma.com |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
Q&A For Mayne Pharma Group Limited Stock
What is a current HG6.F stock price?
Mayne Pharma Group Limited HG6.F stock price today per share is 3.02 EUR.
How to purchase Mayne Pharma Group Limited stock?
You can buy HG6.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mayne Pharma Group Limited?
The stock symbol or ticker of Mayne Pharma Group Limited is HG6.F.
Which industry does the Mayne Pharma Group Limited company belong to?
The Mayne Pharma Group Limited industry is Drug Manufacturers-General.
How many shares does Mayne Pharma Group Limited have in circulation?
The max supply of Mayne Pharma Group Limited shares is 86.48M.
What is Mayne Pharma Group Limited Price to Earnings Ratio (PE Ratio)?
Mayne Pharma Group Limited PE Ratio is now.
What was Mayne Pharma Group Limited earnings per share over the trailing 12 months (TTM)?
Mayne Pharma Group Limited EPS is -1.95 EUR over the trailing 12 months.
Which sector does the Mayne Pharma Group Limited company belong to?
The Mayne Pharma Group Limited sector is Healthcare.